Andrew Conner, MD
Neurological Surgery · Oklahoma City, OKNPI 1487948642
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (31.4%), food and beverage and grants — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by Medtronic at 38.6% of the total. Reporting peaked in 2019 at $10,213 and has fallen 70.0% since, to $3,063 in 2025.
Across 164 payments — averaging $171.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$11K
- Clearpoint Neuro, Inc.$7K
- Insightec,inc$4K
- Abbott$2K
- Boston Scientific$1K
- Neuropace, Inc.$1K
- plus $967 from 12 others
What the payments were for
- Consulting fees$4,00014%
- Speaking & faculty fees$1,5005%
- Grants$6,25022%
- Travel & lodging$8,84831%
- Food & beverage$7,53927%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 64 | $10,851 |
| Clearpoint Neuro, Inc. | 9 | $7,165 |
| Insightec,inc | 15 | $3,788 |
| Abbott | 24 | $2,446 |
| Boston Scientific | 27 | $1,483 |
| Neuropace, Inc. | 8 | $1,437 |
| Zimmer Biomet | 3 | $268 |
| Nevro Corp. | 1 | $135 |
| Axogen | 2 | $127 |
| Livanova USA, Inc. | 2 | $109 |
| Johnson & Johnson | 1 | $78 |
| Brainlab, Inc. | 1 | $68 |
| Globus Medical | 1 | $51 |
| Baxter Healthcare | 2 | $35 |
| Integra Lifesciences Corporation | 1 | $29 |
| Stryker | 1 | $25 |
| Smith+Nephew | 1 | $24 |
| Viiv Healthcare Company | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ACTIVA$7,010
- CLEARPOINT$6,968
- Exablate$3,374
- INFINITY$1,640
- PERCEPT PC BRAINSENSE$1,335
- RNS System$1,188
- INTELLIS$576
- ADAPTIVESTIM$501
- Infinity DBS Pulse Generators$286
- VERCISE$254
- ROSA$145
- Omnia$135
- CoverEdge 32$128
- O-ARM-Spine$121
- WaveWriter Alpha Prime 16$112
How this compares
$28,137 in reported general payments places this provider in the 80th percentile of 80 neurological surgery providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dexamethasone | 12 | $224 |
Paid to pharmacies, not to this prescriber.
Other neurological surgery in Oklahoma City
- Brian SnellOklahoma City$3.7M
- Fadi NasrOklahoma City$1.6M
- Robert TibbsOklahoma City$537K
- Michael HahnOklahoma City$267K
- Isaac KarikariOklahoma City$137K
- Joseph CoxOklahoma City$123K
- Hakeem ShakirOklahoma City$63K
- Robert WieneckeOklahoma City$40K
- Muhammad JanjuaOklahoma City$33K
- Caple SpenceOklahoma City$31K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.